CANNARA BIOTECH INC (LOVE.CA) Stock Price, Forecast & Analysis

TSX-V:LOVE • CA13765U2002

1.83 CAD
-0.06 (-3.17%)
Last: Feb 20, 2026, 07:00 PM

LOVE.CA Key Statistics, Chart & Performance

Key Statistics
Market Cap175.28M
Revenue(TTM)112.36M
Net Income(TTM)11.81M
Shares95.78M
Float44.63M
52 Week High2.07
52 Week Low1.06
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)0.13
PE14.08
Fwd PE9.06
Earnings (Next)04-27
IPO2019-01-14
Sector
GICS SectorConsumer Staples
GICS IndustryPersonal Care Products
GICS IndustryGroupHousehold & Personal Products
GICS SubIndustryPersonal Care Products
LOVE.CA short term performance overview.The bars show the price performance of LOVE.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 2 -2 4 -4 6 -6

LOVE.CA long term performance overview.The bars show the price performance of LOVE.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60 80 100

The current stock price of LOVE.CA is 1.83 CAD. In the past month the price decreased by -7.58%. In the past year, price increased by 41.86%.

CANNARA BIOTECH INC / LOVE Daily stock chart

LOVE.CA Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to LOVE.CA. When comparing the yearly performance of all stocks, LOVE.CA turns out to be only a medium performer in the overall market: it outperformed 64.78% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
LOVE.CA Full Technical Analysis Report

LOVE.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to LOVE.CA. LOVE.CA has an average financial health and profitability rating.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
LOVE.CA Full Fundamental Analysis Report

LOVE.CA Financial Highlights

Over the last trailing twelve months LOVE.CA reported a non-GAAP Earnings per Share(EPS) of 0.13. The EPS increased by 76.5% compared to the year before.


Industry RankSector Rank
PM (TTM) 10.51%
ROA 6.79%
ROE 10.62%
Debt/Equity 0.29
Chartmill High Growth Momentum
EPS Q2Q%-57.14%
Sales Q2Q%20.11%
EPS 1Y (TTM)76.5%
Revenue 1Y (TTM)28.06%
LOVE.CA financials

LOVE.CA Forecast & Estimates

5 analysts have analysed LOVE.CA and the average price target is 3.57 CAD. This implies a price increase of 95.08% is expected in the next year compared to the current price of 1.83.

For the next year, analysts expect an EPS growth of 60% and a revenue growth 16.54% for LOVE.CA


Analysts
Analysts80
Price Target3.57 (95.08%)
EPS Next Y60%
Revenue Next Year16.54%
LOVE.CA Analyst EstimatesLOVE.CA Analyst Ratings

LOVE.CA Ownership

Ownership
Inst Owners0.23%
Ins Owners27.98%
Short Float %N/A
Short RatioN/A
LOVE.CA Ownership

About LOVE.CA

Company Profile

LOVE logo image Cannara Biotech, Inc. engages in the production of premium-grade cannabis and cannabis-derivative products. The company is headquartered in Vancouver, British Columbia and currently employs 452 full-time employees. The company went IPO on 2019-01-14. The firm operates through its wholly owned subsidiaries, Cannara Biotech (Quebec) Inc. and Cannara Biotech (Valleyfield) Inc. The company owns two mega cultivation facilities based in Quebec spanning over 1,650,000 square feet and provides up to 100 000 kilograms of annualized cultivation output. The company operates in two segments: Cannabis operations and Real estate operations. The Cannabis operations encompass the cultivation, processing and sale of dried cannabis and cannabis derivatives mainly for the Canadian market. The Real estate operations is related to the Farnham and Valleyfield building. The firm's brand portfolio includes Tribal, Nugz, and Orchid CBD. Tribal delivers grade cannabis products. Orchid CBD is a wellness brand that provides CBD-rich cannabis.

Company Info

CANNARA BIOTECH INC

Suite 2050 - 1055, West Georgia Street

Vancouver BRITISH COLUMBIA V6E 3P3 CA

Employees: 13

LOVE Company Website

LOVE Investor Relations

Phone: 15149139136.0

CANNARA BIOTECH INC / LOVE.CA FAQ

What does LOVE do?

Cannara Biotech, Inc. engages in the production of premium-grade cannabis and cannabis-derivative products. The company is headquartered in Vancouver, British Columbia and currently employs 452 full-time employees. The company went IPO on 2019-01-14. The firm operates through its wholly owned subsidiaries, Cannara Biotech (Quebec) Inc. and Cannara Biotech (Valleyfield) Inc. The company owns two mega cultivation facilities based in Quebec spanning over 1,650,000 square feet and provides up to 100 000 kilograms of annualized cultivation output. The company operates in two segments: Cannabis operations and Real estate operations. The Cannabis operations encompass the cultivation, processing and sale of dried cannabis and cannabis derivatives mainly for the Canadian market. The Real estate operations is related to the Farnham and Valleyfield building. The firm's brand portfolio includes Tribal, Nugz, and Orchid CBD. Tribal delivers grade cannabis products. Orchid CBD is a wellness brand that provides CBD-rich cannabis.


What is the stock price of CANNARA BIOTECH INC today?

The current stock price of LOVE.CA is 1.83 CAD. The price decreased by -3.17% in the last trading session.


Does LOVE stock pay dividends?

LOVE.CA does not pay a dividend.


What is the ChartMill technical and fundamental rating of LOVE stock?

LOVE.CA has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


On which exchange is LOVE.CA stock listed?

LOVE.CA stock is listed on the TSX Venture Exchange exchange.


What is the employee count for LOVE stock?

CANNARA BIOTECH INC (LOVE.CA) currently has 13 employees.